Environmental Health

U.S. Fragrance Regulation Gaps: Trade Secrets, MoCRA, and Patchwork States

FDA fragrance trade-secret labeling, uneven cleaning-product rules, and slow allergen rulemaking leave U.S. shoppers under-informed.

BY ELENA VOSS 4 MIN READ 3 SOURCES

U.S. cosmetics label with fragrance highlighted and gavel icon soft-focus, no people — Illustration: Health Canon

In short

U.S. law still allows trade-secret “fragrance” on many labels. MoCRA and state right-to-know laws narrow—not erase—the gap. Legality ≠ full chemical transparency.

American fragrance policy is a patchwork: federal trade-secret defaults, incremental MoCRA modernization, and blue-state disclosure experiments. Shoppers need literacy because labels under-inform.

This article is informational and editorial only. It is not medical advice, diagnosis, or a treatment plan. Numbers and literature ranges cited here are not personal prescriptions. Consult a qualified clinician before changing medications, supplements, diet, equipment, or management of a diagnosed condition. Seek urgent care for emergencies.

What is the federal baseline?

Cosmetic fragrance trade-secret listing remains foundational FDA-described practice.

Pre-MoCRA oversight was widely criticized as weaker than drug/device frameworks.

Steinemann research documented both chemical emissions and public unawareness of non-disclosure.

Where is MoCRA a real upgrade?

Mandatory registration, records, and serious adverse event processes improve accountability.

Fragrance allergen labeling authority aims at EU-like named allergens—watch final rules and timelines.

It still may not force full disclosure of every non-allergen solvent in a perfume accord.

Key reference points
Layer	Strength	Gap
FDA fragrance word	Legal clarity for trade secrets	Hides mixture
MoCRA	Modern oversight + allergen path	Phased, not full formula
State RTK	Cleaning product transparency	Not all states/categories
Retailer standards	Market pressure	Uneven
Consumer swaps	Immediate dose cut	Not structural reform

How do states fill holes?

California cleaning-product disclosure rules and ingredient websites set practical precedents.

Prop 65 warnings address some listed chemicals but are easy to misread as universal hazard ranks.

Retailer private standards sometimes exceed federal minimums.

What is the consumer action layer?

Assume incomplete disclosure until proven otherwise. Reward transparent brands with purchases.

Reduce leave-on and air-care fragrance regardless of statute speed.

Support clear allergen labeling rules with public comments when FDA dockets open—policy is a pathway, products are today’s dose.

Sources: FDA fragrances in cosmetics; MoCRA overview; Steinemann disclosure findings.

Readers should dual-source primary literature, translate slogans into exposure units and effect sizes, and rank interventions by expected value under uncertainty. Cheap reversible steps often outrank extreme protocols. Opportunity cost is real: hours spent on unvalidated tests are hours not spent on sleep, training, protein adequacy, and primary care. Sex, life stage, comorbidities, medications, and geography change interpretation. Prefer falsifiable claims with named endpoints over multi-disease cure lists. Update beliefs when stronger trials appear rather than freezing identity around a single paper or influencer narrative. Measured curiosity beats both panic and complacency. Further reading should prioritize primary sources and consensus documents over secondary social summaries. When evidence is mixed, state both the signal and the limits in the same paragraph. When evidence is strong, still avoid overclaiming universality across populations.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Sources & citations

Frequently asked

Questions & answers

Why can U.S. labels say only “fragrance”?

FDA explains that fragrance and flavor ingredients may be declared as “fragrance” or “flavor” because formulas can be trade secrets under packaging law frameworks. A single word can stand in for dozens to hundreds of chemicals. That design prioritizes formula confidentiality over public composition transparency.

What does MoCRA change?

The Modernization of Cosmetics Regulation Act of 2022 strengthens FDA’s cosmetics toolkit—facility registration, adverse event systems, and direction toward fragrance allergen labeling rules among other provisions. Implementation is phased; MoCRA is not instantaneous full-formula disclosure. Treat it as modernization, not EU-level allergen annex completion overnight.

Are cleaning products regulated like cosmetics?

Not identically. Many air-care and cleaning products historically fell under different federal frameworks with weaker ingredient disclosure than cosmetics, though state laws (notably California cleaning-product right-to-know) improved online and label transparency for some categories. Always check category-specific rules. This is general editorial context, not individualized medical advice; match decisions to clinical care when stakes are high.

Do “phthalate-free” claims fix the gap?

They help for one chemical class when truthful, but fragrance mixtures can still include musks, allergens, and other solvents. Claims are not standardized federal full-composition labels. Prefer brands that publish complete allergen and solvent disclosures. This is general editorial context, not individualized medical advice; match decisions to clinical care when stakes are high.

What can shoppers do while law catches up?

Choose fragrance-free products with full ingredient lists; use state disclosure databases for cleaners; prefer EU-market or fully transparent brands; reduce product count. Political attention to allergen rulemaking matters, but household dose reduction does not require waiting for perfect statutes. This is general editorial context, not individualized medical advice; match decisions to clinical care when stakes are high.